iMDK (quarterhydrate)
Product Specifications
UNSPSC Description
iMDK quarterhydrate is a potent PI3K inhibitor and inhibits the growth factor MDK (also known as midkine or MK). iMDK quarterhydrate suppresses non-small cell lung cancer (NSCLC) cooperatively with A MEK inhibitor without harming normal cells and mice[1].
Target Antigen
PI3K
Type
Reference compound
Related Pathways
PI3K/Akt/mTOR
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/imdk-quarterhydrate.html
Purity
99.37
Solubility
DMSO : 3.33 mg/mL (ultrasonic;warming;heat to 60°C)
Smiles
O=C1C(C2=CN3C(SC(CC4=CC=C(F)C=C4)=C3)=N2)=CC5=CC=CC=C5O1.O
Molecular Weight
380.91
References & Citations
[1]Naomasa Ishida, et al. A novel PI3K inhibitor iMDK suppresses non-small cell lung Cancer cooperatively with A MEK inhibitor. Exp Cell Res. 2015 Jul 15;335(2):197-206.Nat Commun. 2023 Jul 31;14(1):4600.|Cell Discov. 2024 Oct 22;10(1):110.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-110171A/iMDK-quarterhydrate-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-110171A/iMDK-quarterhydrate-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6347786-01 0.1 mL
SIRPG, ID (SIRPG, SIRPB2, Signal-regulatory protein gamma, CD172 antigen-like family member B, Signal-regulatory protein beta-2, CD172g) (MaxLight 490)
Ask
View Details MBS6347786-02 5x 0.1 mL
SIRPG, ID (SIRPG, SIRPB2, Signal-regulatory protein gamma, CD172 antigen-like family member B, Signal-regulatory protein beta-2, CD172g) (MaxLight 490)
Ask
View Details 
